Abstract
Apathy is characterized by diminished goal-directed activity, loss of emotion, and reduced engagement in social interactions. It is a common neuropsychiatric symptom in Alzheimer’s disease (AD) and is present throughout every stage of the disease. This chapter comprehensively discusses the prevalence of apathy, its impact on patient and caregiver outcomes, the diagnostic criteria and validated scales used in the assessment of apathy, the neurobiology of this neuropsychiatric symptom, and findings from studies investigating the treatment of apathy in AD. Recommendations for future research include validating apathy scales to identify and measure apathy in AD, and consideration of neuroimaging techniques and biomarker analyses to better predict treatment response.